Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: A pilot study in patients with hereditary Nox2 deficiency [3]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 8, 2006, Pages

  Violi, F ^a   Sanguigni, V ^b   Loffredo, L ^a   Carnevale, R ^a   Buchetti, B ^a   Finocchi, A ^b   Tesauro, M ^b   Rossi, P ^b   Pignatelli, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; ARTERY DILATATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC DISORDER; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTHESIS; LETTER; MALE; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2 DEFICIENCY; STUDENT T TEST; UPREGULATION; VASODILATATION; ARTERY; GENETICS; INBORN ERROR OF METABOLISM; ISCHEMIA; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ARTERIES; HUMANS; ISCHEMIA; MALE; MEMBRANE GLYCOPROTEINS; METABOLISM, INBORN ERRORS; MIDDLE AGED; NADPH OXIDASE; OXIDATIVE STRESS; PILOT PROJECTS; VASODILATION;

EID: 33746803850     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000229710.13054.2d     Document Type: Letter

References (10)

1. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
2. Keaney JF. Oxidative stress and the vascular wall NADPH oxidase take center stage. Circulation. 2005;112:2585-2588.
3. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation. 2005;112:2677-2685.
4. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation. 2004;109:1795-1801.
5. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170-200.
6. Bertuglia S, Giusti A. Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion. Am J Physiol Heart Circ Physiol. 2003;285:H1064-H1071.
7. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
8. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
9. Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A. 2003;100:768-770.
10. Pollock DM. Endothelin, angiotensin and oxidative stress in hypertension. Hypertension. 2005;45:477-480.